Levels Health Secures $10M Series A Extension to Combat Metabolic Health Crisis
Key Highlights Levels Health raises $10M Series A Extension to expand its mission. $3M in crowdfunding from over 2,000 investors included in…
Chartis to Receive Majority Investment from Blackstone for Continued Growth
Key Highlights Chartis secures majority investment from Blackstone to support its continued growth in healthcare advisory. Blackstone’s investment will…
Rx Save Card Secures $1.7M Seed Funding to Revolutionize Employer-Sponsored Prescription Benefits
Key Highlights Rx Save Card completed a $1.7M seed funding round led by Distributed Ventures. Solution addresses the gap between employer…
Seaport Therapeutics Appoints Dr. David Wheadon to Board of Directors
Key Highlights Seaport Therapeutics appoints Dr. David Wheadon to its Board of Directors. Dr. Wheadon has over three decades…
PracticeTek Appoints Mike Sharp as President to Lead Next-Generation Innovation
Key Highlights Mike Sharp appointed as President of PracticeTek, a leading healthcare software provider. Strategic move to enhance…
Carlyle to Acquire Baxter’s Kidney Care Segment for $3.8 Billion, Establishing Vantive
Key Highlights Baxter sells Kidney Care segment to Carlyle for $3.8 billion, forming Vantive. Transaction supports Baxter’s strategic realignment and debt reduction.…
James F. Amatruda, M.D., Ph.D., Appointed Director of Cancer and Blood Disease Institute at CHLA
Key Highlights James F. Amatruda, M.D., Ph.D., appointed Director of the Cancer and Blood Disease Institute at CHLA.…
Rejoyn™: First FDA-Cleared Digital Therapeutic for MDD Symptoms Launches
Key Highlights Rejoyn™ cleared by FDA in March 2024 for treating major depressive disorder (MDD) symptoms. Available via prescription, Rejoyn™…
UChicago Medicine Partners with Loyal for Enhanced Digital Patient Engagement
Key Highlights UChicago Medicine partners with Loyal to enhance digital patient engagement. Loyal’s Directory Listings solution will manage and update provider and…
Neuronetics to Acquire Greenbrook TMS in Strategic All-Stock Transaction
Key Highlights Neuronetics to acquire all Greenbrook TMS shares in an all-stock deal. Combined company to enhance patient…